Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096937 · ClinicalTrials.gov registry record
Journey of Hope in Appalachia: Supporting Resilience in the Region's Youth
A clinical trial of Adverse Childhood Experiences, sponsored by Gia Mudd.
- Completed
- Registry status
- 42
- Enrollment target
- 2
- Study locations
NCT04096937 is a study of Adverse Childhood Experiences that has completed, run by Gia Mudd. The registered enrollment target is 42 participants, below the 327-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04096937, a study of Adverse Childhood Experiences, has completed, sponsored by Gia Mudd.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
Rural youth have heightened exposure to adverse childhood experiences (ACES) such as poverty, social isolation, chronic hunger, and drug use in the home. These threats can lead to downstream problems with emotion regulation, substance abuse, and heightened vulnerability to chronic disease. Resilience is the capacity to adapt positively in the face of such disadvantage. Youth resilience interventions can buffer the negative effects of ACES. Unfortunately, rural schools and other youth-serving agencies often have inadequate capacity to provide such interventions. Thus, there is a critical need to develop cost-effective, sustainable, and culturally-relevant youth resilience interventions that can be delivered by trained personnel with dedicated time and resources. WVU, UK, and Save The Children have a long-term goal to establish a sustained community-engaged research partnership to promote resilience in Appalachian youth. This is a community-based participatory research (CBPR)-guided study being conducted for the purpose of developing a culturally relevant, intervention to promote Appalachian youth resilience. The intervention, called Journey of Hope in Appalachia (JOHA), has as it's starting point Save The Children's evidence-based Journey of Hope (JOH) program that targets youth experiencing acute stress from natural disasters and similar events. This program will be culturally adapted to promote resilience among Appalachian youth experiencing ACES. JOHA will incorporate positive aspects of Appalachian culture (e.g., storytelling, theater, music) and will be designed for sustainability and eventual dissemination by Save through the Appalachian Translational Research Network (ATRN) and other regional Networks.
Conditions Studied
Interventions
- OTHER Focus groups
Study Locations (2)
Kentucky
- University of Kentucky, Center of Excellence in Rural Health - Hazard
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-03-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04096937
The ClinicalTrials.gov registry entry for NCT04096937 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 327-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (87% lower). The listed sponsor is Gia Mudd, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adverse Childhood Experiences appearing as the primary indexed condition, and to 1 intervention - of which Focus groups is the first listed.
NCT04096937 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, West Virginia.
Frequently Asked Questions
What is clinical trial NCT04096937 about?
NCT04096937 is a clinical study titled "Journey of Hope in Appalachia: Supporting Resilience in the Region's Youth". Rural youth have heightened exposure to adverse childhood experiences (ACES) such as poverty, social isolation, chronic hunger, and drug use in the home. These threats can lead to downstream problems with emotion regulation, substance abuse, and heightened vulnerability to chronic disease. Resilienc...
What is the current status of trial NCT04096937?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2021-05-01. Estimated completion is 2022-03-22.
What conditions does trial NCT04096937 study?
This clinical trial studies the following conditions: Adverse Childhood Experiences.
What interventions are being tested in trial NCT04096937?
The interventions under investigation include: Focus groups (OTHER).
Who is sponsoring clinical trial NCT04096937?
This trial is sponsored by Gia Mudd, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04096937 being conducted?
This trial has 2 study locations across Kentucky, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Childhood Experiences
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
School Violence Exposure as an Adverse Childhood Experience
RECRUITING
-
Building Resilient Families
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.